SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-006372
Filing Date
2020-07-14
Accepted
2020-07-14 06:05:14
Documents
5
Period of Report
2020-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_071320.htm 8-K 32008
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-1.htm EX-5.01 11078
3 PLACEMENT AGENCY AGREEMENT ex10-1.htm EX-10.01 48669
4 FORM OF SECURITIES PURCHASE AGREEMENT ex10-2.htm EX-10.02 239060
5 PRESS RELEASE ex99-1.htm EX-99.1 15314
  Complete submission text file 0001387131-20-006372.txt   347385
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 201026258
SIC: 2834 Pharmaceutical Preparations